Latigo Bio

Latigo Biotherapeutics is a clinical-stage biopharmaceutical company developing innovative non-opioid pain medicines intended to stop pain transmission rapidly and effectively without addiction risk. It aims to address significant unmet medical needs and change the treatment paradigm for pain. The company is building a broad pipeline of pain therapeutics, drawing on expertise in pain biology, clinical translation, and trial execution to deliver meaningful patient benefit.